CDSCO License for Wrist joint carpal trapezium polymer prosthesis
Medical Device Information
Intended Use
Intended to be implanted to replace the carpal trapezium bone of the wrist

Comprehensive Guide to CDSCO Licensing for Wrist Joint Carpal Trapezium Polymer Prosthesis (Class C Orthopaedic Implant)
As specialists with over 25 years of experience and having supported 500+ medical device companies, we understand the critical regulatory landscape surrounding advanced orthopaedic implants like the Wrist Joint Carpal Trapezium Polymer Prosthesis. This device, intended to replace the carpal trapezium bone in the wrist, falls under Class C risk classification according to CDSCO's regulations, governed by Notification 29/Misc/3/2017-DC (292) dated 06.06.2018. Navigating the licensing process for such high-risk implantable devices requires precise documentation, expert preparation, and strategic planning to ensure timely market entry in India.
CDSCO Regulatory Framework for Orthopaedic Implants
The Central Drugs Standard Control Organization (CDSCO) mandates rigorous evaluation for implantable devices due to their criticality and risk profile. Orthopaedic implants like the Wrist Joint Carpal Trapezium Polymer Prosthesis are governed under the Indian Medical Device Rules (IMDR) and require compliance with quality, safety, and performance standards before manufacturing or import.
Risk Classification and License Requirements for Class C Devices
Class C devices represent moderate to high risk products. As such, the manufacturing license must be obtained through the Central Licensing Authority via the MD9 license (Application Form MD7). This process involves comprehensive product testing, documentation, expert audits, and regulatory scrutiny.
For imports, the MD15 import license is mandatory, granted by the Central Licensing Authority after detailed review of manufacturing and quality credentials.
For a detailed understanding of medical device classifications, manufacturers can refer to our Medical Device Classification guide.
Manufacturing License Process (MD9) for Wrist Joint Carpal Trapezium Polymer Prosthesis
Obtaining the MD9 manufacturing license involves several key steps:
Test License Application (Form MD13): Before full license application, manufacturers must secure a test license enabling product testing. This step takes approximately 1.5-2 months.
Product Testing: The device must be tested in CDSCO-approved laboratories. Given the implantable nature, biocompatibility, mechanical integrity, and sterility tests are critical. Refer to the list of Testing Laboratories for approved facilities.
Documentation Preparation: Assemble comprehensive dossiers including Device Master File, Plant Master File, Essential Principles Checklist, Risk Management File, and Quality Management System documents. Our Device Master File guide and Plant Master File guide provide practical insights.
Application Submission: Submit the MD9 application (Form MD7) through the CDSCO MD Online Portal. Include all required documents and test reports.
Audit by CDSCO Inspectors: A thorough inspection of the manufacturing facility and quality systems is conducted by CDSCO officials.
Response to Queries: Address any departmental or audit queries promptly to avoid delays.
License Grant: Upon successful review, the MD9 license is issued.
Manufacturing License Documents Required
For Class C orthopaedic implants, the following documents are essential:
- Company Constitution and Registration Proof
- Proof of Ownership or Lease of Manufacturing Premises
- Technical Staff Qualifications and Experience Details
- Fire Safety NOC
- Pollution Control Board NOC
- Device Master File (DMF)
- Plant Master File (PMF)
- Essential Principles Checklist
- Risk Management File (complying with ISO 14971) – for detailed guidance, see our Risk Management resource
- Product Test Reports from CDSCO-approved labs
- Labels and Instructions for Use (IFU)
- Quality Management System Documents (ISO 13485:2016 preferred)
Import License Process (MD15) for Wrist Joint Carpal Trapezium Polymer Prosthesis
Importers seeking to bring this Class C device into India must apply for the MD15 import license. The process includes:
Documentation Preparation: Gather manufacturing license from the country of origin, Free Sale Certificate, ISO 13485 certification, CE Certificate or equivalent, Device and Plant Master Files, and wholesale license.
Application Submission: Submit Form MD14 for MD15 license via the CDSCO MD Online Portal.
Departmental Review and Queries: Respond quickly to any clarifications.
Grant of Import License: License is usually issued within 5-6 months.
Import License Documents Required
- Valid Manufacturing License of the foreign manufacturer
- Free Sale Certificate or equivalent
- ISO 13485:2016 Certificate
- CE Certificate or equivalent regulatory approval
- Device Master File
- Plant Master File
- Wholesale License in India
- Company Constitution and Registration Proof
Timeline and Processing Duration
The entire MD9 manufacturing license process usually spans 4-5 months, including test license issuance, product testing, dossier preparation, audits, and query resolution. The test license phase alone takes about 1.5-2 months.
Import license (MD15) processing ranges from 5 to 6 months depending on completeness of documents and regulatory workload.
Government Fees and Costs
- MD9 Manufacturing License Fees: Rs. 50,000 per application + Rs. 1,000 per product
- MD13 Test License Fees: Applicable as per CDSCO norms
- MD15 Import License Fees: For Class C devices, Rs. 3,000 per site + Rs. 1,500 per product
Budgeting for notified body audits, testing fees at government-approved laboratories, and consultancy support is crucial to avoid unexpected expenses.
Common Challenges and Solutions
Delays in Product Testing: Implantable devices require complex testing; choosing accredited labs early and scheduling tests promptly prevents bottlenecks.
Incomplete Documentation: Using standardized templates for Device and Plant Master Files and Risk Management Files ensures completeness.
Audit Non-compliance: Proactive preparation for CDSCO audits by conducting internal mock audits can minimize negative findings.
Query Resolution Delays: Assigning dedicated personnel for regulatory liaison expedites responses.
Expert Consultation and Support
Given the complexity of Class C device licensing, partnering with experienced regulatory consultants accelerates approvals and mitigates risks. Our team has successfully navigated the CDSCO process for numerous orthopaedic implant manufacturers, ensuring compliance and market readiness.
Getting Started with Your CDSCO License Application
Assess Your Device Classification: Confirm your device is Class C under CDSCO guidelines.
Prepare Essential Documentation: Begin compiling company, technical, and product-related documents.
Apply for Test License (MD13): Submit the test license application early through the CDSCO MD Online Portal.
Engage Accredited Testing Laboratories: Schedule your product testing promptly to avoid delays.
Develop Comprehensive Dossiers: Use our Device Master File guide and Plant Master File guide for detailed instructions.
Plan for CDSCO Audit: Prepare your manufacturing site and QMS for inspection.
Submit MD9 Application: Once testing and documentation are complete, apply for the manufacturing license.
Monitor Application Status and Respond to Queries: Stay proactive in communications through the CDSCO portal.
By following these actionable steps and leveraging our expert insights, manufacturers and importers of Wrist Joint Carpal Trapezium Polymer Prosthesis can confidently navigate the regulatory pathway for successful entry into the Indian market.